Study Finds Gaps in Publicly Funded Dialysis Programme

Study Finds Gaps in Publicly Funded Dialysis Programme

  • Research Stash
  • News
  • 1.8K

The incidence of chronic kidney disease is rising rapidly in India. It is ranked as the ninth leading cause of death in India as per the estimates made by a global study in 2016.

Among the response mounted to address the challenge was the national dialysis programme launched in 2014, envisaging setting up dialysis centers in all the districts.

A new study now has shown that though free treatment under a publicly funded dialysis programme could allow more people access this expensive treatment, it would not be able to address all barriers to ensure long-term success.

The study is based on an analysis of 13,118 beneficiaries who received hemodialysis over a period of four years (2008-12) for end-stage kidney disease under the Rajiv Gandhi Aarogyashri Community Health Insurance Scheme (RACHIS) introduced in 2007 by the Government of unified Andhra Pradesh.

It showed that there was a steady rise in the number of persons accessing treatment, confirming a high unmet need for dialysis but survival rates were suboptimal. About 10 percent of all the people who started hemodialysis had died and another 36 percent had stopped coming to dialysis centers after six months.

The study, done by the George Institute for Global Health India, found that the total cost of dialysis-related care was US dollars 63.2 million, accounting for 3.1 percent of all claim expenses under the scheme.

Noting that the high drop-out rate had been noticed in smaller studies conducted earlier too, Professor Vivekanand Jha, Executive Director of the George Institute for Global Health, India, said there appeared to be several additional barriers.

“These could include out-of-pocket expenses for travel to dialysis units; management of associated medical conditions the costs of which were not covered by the scheme; loss of income; and caregiver burden. Exploration of these factors requires additional studies”, he said. The study has been published in journal Kidney International. (India Science Wire)

By Sunderarajan Padmanabhan

Journal Article [Image Credit, Flickr, peigov]

Utilization, costs, and outcomes for patients receiving publicly funded hemodialysis in India

If you liked this article, then please subscribe to our YouTube Channel for the latest Science & Tech news. You can also find us on Twitter & Facebook.

The study is based on an analysis of 13,118 beneficiaries who received hemodialysis over a period of four years (2008-12) for end-stage kidney disease under the Rajiv Gandhi Aarogyashri Community Health Insurance Scheme (RACHIS) introduced in 2007 by the Government of unified Andhra Pradesh.

It showed that there was a steady rise in the number of persons accessing treatment, confirming a high unmet need for dialysis but survival rates were suboptimal. About 10 percent of all the people who started hemodialysis had died and another 36 percent had stopped coming to dialysis centers after six months.

The study, done by the George Institute for Global Health India, found that the total cost of dialysis-related care was US dollars 63.2 million, accounting for 3.1 percent of all claim expenses under the scheme.

Noting that the high drop-out rate had been noticed in smaller studies conducted earlier too, Professor Vivekanand Jha, Executive Director of the George Institute for Global Health, India, said there appeared to be several additional barriers.

“These could include out-of-pocket expenses for travel to dialysis units; management of associated medical conditions the costs of which were not covered by the scheme; loss of income; and caregiver burden. Exploration of these factors requires additional studies”, he said. The study has been published in journal Kidney International. (India Science Wire)

By Sunderarajan Padmanabhan

Journal Article [Image Credit, Flickr, peigov]

Utilization, costs, and outcomes for patients receiving publicly funded hemodialysis in India

If you liked this article, then please subscribe to our YouTube Channel for the latest Science & Tech news. You can also find us on Twitter & Facebook.

" }
India to Enhance Natural Defence Against COVID-19

India to Enhance Natural Defence Against COVID-19

Council of Scientific and Industrial Research has decided to repurpose an approved immunomodulator called Sepsivac to enhance the innate immunity of the body to limit the spread of COVID-19 and fasten the recovery of COVID-19 patients.

  • News
  • 2.1K
Read more
New Study Shows That Delhi’s Odd-Even Scheme Led to Increase in Emissions

New Study Shows That Delhi’s Odd-Even Scheme Led to Increase in Emissions

There seems to be no early end to the debate on whether the odd-even scheme implemented by Delhi Government in January 2016 was a success or not.

  • News
  • 2.5K
Read more
Kidney Patients Are More Vulnerable To COVID-19 Infections

Kidney Patients Are More Vulnerable To COVID-19 Infections

The COVID-19 pandemic is throwing up unique challenges for health systems. It presents particular challenges for patients who receive regular hemodialysis. These patients with damaged kidneys, also known as uremic patients, are particularly vulnerable to infection and may exhibit greater variations in clinical symptoms and infectivity.

  • News
  • 2.6K
Read more

Internet is huge! Help us find great content

Newsletter

Never miss a thing! Sign up for our newsletter to stay updated.

About

Research Stash is a curated collection of tools and News for S.T.E.M researchers

Have any questions or want to partner with us? Reach us at [email protected]

Navigation

Submit